Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
- 3rd side (hint)
List the autosomal dominant diseases |
Very Powerful DOMINANT Humans V: Von-hippel and Von willebrand P: Pseudohypoparathyroidism D: Dystrofia Mytonica O: Osteogenesis imperfecta M: Marfan syndrome I: Intermittent porphyria N:Neurofibromatosis I A: Acondroplasia, adult polycystic kidney disease (ADPKD) and adenomatous familial polyposis N: Neurofibromatosis type 2 T: Tuberus sclerosis H: Hypercholesterolemia, Hereditary hemorrhagic telengiectasia, hereditary spherocytosis, huntington disease |
Very Powerful DOMINANT Humans |
|
Chest pain, dyspnea on exertion, ST elevation, Troponin I is elevated, HR: 110 bpm, RR: 25/min, yellowish papules on upper eyelids |
Hypercholesterolemia |
|
|
Fatigue and skin yellowing, anemic in the past, recent viral illness, HR:120 bpm, jaundice, Hgb: 8.1, MCV: 85, MCHC: 39, increased cell hemolysis |
Hereditary spherocytosis |
|
|
Can lead to MI before age 20 |
Familial hypercholesterolemia |
|
|
Tendon xanthomas, classically on alchilles tendon |
Familial hypercholesterolemia |
|
|
How does the fact that a patient is homozygote or heterozygote for familial hypercholesterolemia affect the prognosis? |
Hetero is less severe. With LDL levels over 300, Homo with LDL over 700 |
|
|
Diagnosis of hereditary spherocytosis is made with what criteria? |
- Spheroid erythrocytes - Hemolytic anemia - Abnormal osmotic fragility test |
|
|
Why do patients with spherocytosis have high blood viscocity? |
BC their RBC are not flexible due to spectrin or ankyrin defect |
|
|
What labs are altered in patients with hereditary spherocytosis ? |
high MCHC, blood viscosity, possibly evidence of recent viral infection |
|
|
What are the 7 C's of huntington disease? |
Chorea, caudate atrophy, decreased actylcholine (&GABA) in the brain, CAG trinucleotide repeat order, Cognitive decline, Cuarenta (years old), Chromosome cuatro |
|
|
Fibrillin-1 gene mutation |
Marfan syndrome |
|
|
RET gene |
MEN2A and 2B in Multiple endocrine neoplasias (MEN) |
|
|
MEN1 gene |
Associated to subtype MEN1 |
|
|
Characterized by familial tumors of endocrine glands |
MEN (1,2A, 2B) |
|
|
Associated to pancreas, parathyroid and pituitary neoplasms |
MEN 1- MEN 1 gene |
|
|
Associated to medullary thyroid, mucosal tumor and pheochromocytomas |
MEN2B - RET gene |
|
|
Associated to pheochromocytoma, medullary thyroid and parathyroid tumors |
MEN 2A - RET gene |
|
|
Caused by mutations in the NFI gene on chromosome 17:17 |
Neurofibromatosis type I (Von Recklinghausen) |
|
|
Caused by mutations in the NF2 gene on chromosome 22 |
Neurofibromatosis type II |
|
|
Neurocutaneous disorder with multi-organ system involvement, characterized by numerous benign hamartomas. |
Tuberous sclerosis |
|
|
Due to mutated hemartin or tuberin gene that cause non-malignant tumors in brain and other organs. |
Tuberous sclerosis |
|
|
Associated to deletion of VHL gene on chromosome 3 |
Von- hippel lindau disease |
|
|
Disorder characterized by development of numerous tumors, both benign and malignant |
Von- hippel lindau disease |
|
|
Associated with hemangioblastomas (retina, cerebellum and medulla), pheochromocytomas and multiple renal cell carcinoma |
Von- hippel lindau disease |
|
|
Seizures, intelectual dissability, cardiac rhabdomyomas, cortical and retinal hemartomas, astrocytomas |
Tuberous sclerosis |
|
|
Hearing loss, bilateral tinnitus, decreased vision, hyperpigmented skin lesion, cerebellar testing difficulty, bilateral catatacts, bilateral decreased hearing, hyperpigmented arm macules |
Neurofibromatosis type 2 |
|
|
Bilateral acoustic schwannomas, juvenile cataracts, nonmalignant brain tumors on CN VIII |
Neurofibromatosis type 2 |
|
|
Associated with floppy mitral valve, dissecting aortic aneurysm, berry aneurysm |
Marfan syndrome |
|
|
Associated with mitral valve prolapse, liver disease, berry aneurysm |
Autosomal dominant polycystic kidney disease |
|
|
Neural tumors and pigmented iris hamartomas (leish nodules) |
Neurofibromatosis type I |
|
|
Cafe au lait spots, scolyosis, leish nodules |
Neurofibromatosis type I |
|
|
Very strong association with colon cancer |
Familial adenomatous polyposis |
|
|
Cystic medial necrosis of the aorta |
Marfan syndrome |
|
|
Defect in fibroblast growth factor receptor (FGF) receptor 3 |
Achondroplasia |
|
|
Flank pain, hematuria, HTN, renal failure, always bilateral, massive englargement of kidneys due to multiple large cysts |
Autosomal dominant polycystic kidney disease (ADPKD) |
|
|
Mutation in PKD1 on chromosome 16:16 |
85% of cases of ADPKD |
|
|
PDK2 mutation on chromosome 4 |
15% of cases of ADPKD |
|
|
Mutations on chromosome 5 - APC gene |
Familial adenomatous polyposis (FAP) |
|
|
Progresses to colon cancer unless colon is resected |
FAP |
|
|
Telangiectasia, recurrent epistaxis, skin discolorations, arteriovenous malformations (AVMs) |
Hereditary hemorrhagic telangiectasia (Osler-weber-rendu) |
|
|
Type of FAP with polyps in the colon and tumors outside the colon. |
Gardners syndrome |
|
|
X-linked frameshift mutation with truncated dystrophin protein and accelerated muscle breakdown |
Muscular dystrophy of duchenne |
|
|
Trinucleotide repeat expansion diseases |
Fragile X syndrome = CGC Freidreich ataxia = GAA Huntington disease = CAG Myotonic dystrophy = CTG |
|